2023

1. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

   The European respiratory journal, Vol. 61, Núm. 2

2. A second update on mapping the human genetic architecture of COVID-19

   Nature

3. A systematic review and meta-analysis of the clinimetric properties of the core outcome measurement instruments for clinical effectiveness trials of nutritional and metabolic interventions in critical illness (CONCISE)

   Critical Care, Vol. 27, Núm. 1

4. Adeno-associated virus 2 infection in children with non-A–E hepatitis

   Nature, Vol. 617, Núm. 7961, pp. 555-563

5. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

   European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

6. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

   Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

7. Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature (Frontiers in Immunology, (2023), 14, (1043631), 10.3389/fimmu.2023.1043631)

   Frontiers in Immunology

8. Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer

   Thrombosis and Haemostasis

9. Genomic investigations of unexplained acute hepatitis in children

   Nature, Vol. 617, Núm. 7961, pp. 564-573

10. Impact of Post-PCI FFR Stratified by Coronary Artery

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 19, pp. 2396-2408

11. Implementation of the ESPEN guideline on clinical nutrition in the intensive care unit (ICU): It is time to move forward!: A position paper from the ‘nutrition in the ICU’ ESPEN special interest group

    Clinical Nutrition ESPEN, Vol. 57, pp. 318-330

12. Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature

    Frontiers in Immunology, Vol. 14

13. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 2, pp. 151-162

14. Lessons from COVID-19 in the management of acute respiratory failure

    Breathe, Vol. 19, Núm. 1

15. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    European Urology

16. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    European Journal of Cancer

17. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    The Lancet, Vol. 401, Núm. 10373, pp. 269-280

18. Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial

    European Journal of Cancer, Vol. 184, pp. 48-59

19. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

    European Journal of Internal Medicine, Vol. 112, pp. 29-36

20. Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study

    European Urology, Vol. 84, Núm. 3, pp. 321-330